(Source: Consort Medical plc) News Release 13 June 2013 Consort Medical plc Preliminary results for the year ended 30 April 2013 Continuing strong performance and strategic execution Consort Medical plc (LSE: CSRT) ("Consort" or the "Group"), a leading designer and manufacturer of drug delivery and device technologies, today announces its audited preliminary results for the year ended 30 April 2013. Financial Highlights1 Like for like performance measures GBPm FY2013 Actuals FY2012 Like for Like Growth FY2012 Actuals Growth 12 months ended 30 April 2013 30 April 2012 30 April 2012 Revenue from products and services 129.5 127.8 1.3% 136.6 (5.2%) Operating profit (before...
↧